Cite

1. Cohen JI. Optimal Treatment for Chronic Active Epstein-Barr Virus Disease. Pediatr transplant. 2009;13:393.10.1111/j.1399-3046.2008.01095.x277603519032417Search in Google Scholar

2. Leonardsson H et al. Hepatitis due to Epstein–Barr virus and cytomegalovirus: clinical features and outcomes. Scand J Gastroenterol. 2017;52:893.10.1080/00365521.2017.131997228446048Search in Google Scholar

3. Kofteridis DP et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011;22:73.10.1016/j.ejim.2010.07.01621238898Search in Google Scholar

4. Oh SH et al. A Case of Ulcerative Colitis Following Acute Hepatitis Induced by Epstein-Barr Virus Infection. Korean J Gastroenterol. 2016;68:104.10.4166/kjg.2016.68.2.10427554218Search in Google Scholar

5. Petrova M, Kamburov V. Epstein-Barr virus: Silent companion or causative agent of chronic liver disease? World J. Gastroenterol. 2010;16:4130.10.3748/wjg.v16.i33.4130293291520806428Search in Google Scholar

6. Yang SI et al. Clinical Characteristics of Primary Epstein Barr Virus Hepatitis with Elevation of Alkaline Phosphatase and γ-Glutamyltransferase in Children. Yonsei Med J. 2014;55:107.10.3349/ymj.2014.55.1.107387490424339294Search in Google Scholar

7. Zhang W et al. Epstein-Barr Virus-Associated Acute Liver Failure Present in a 67-Year-Old Immunocompetent Female. Gastroenterol Res. 2016;9:74.10.14740/gr718e504054927785330Search in Google Scholar

8. Xing Y et al. Chronic active Epstein-Barr virus infection associated with hemophagocytic syndrome and extra-nodal natural killer.T-cell lymphoma in an 18-year-old girl: A case report. Medicine (Baltimore),96,2017.10.1097/MD.0000000000006845542860528489771Search in Google Scholar

9. Lawee D. Mild infectious mononucleosis presenting with transient mixed liver disease: Case report with a literature review. Can Fam Physician. 2007;53:1314.Search in Google Scholar

10. Packman CH. The Clinical Pictures of Autoimmune Hemolytic Anemia. Transfus Med Hemother. 2015;42:317.10.1159/000440656467831426696800Search in Google Scholar

11. Becker JA, Smith JA. Return to Play After Infectious Mononucleosis. Sports Health 2014;6:232.10.1177/1941738114521984400047324790693Search in Google Scholar

12. Malhotra V et al. Infectious mononucleosis with secondary cold agglutinin disease causing autoimmune haemolytic anaemia. BMJ Case Rep, 2009;bcr12.2008.1390.10.1136/bcr.12.2008.1390302824221894246Search in Google Scholar

13. Demirdal T, Dermirtuk N. A rare presentation on EBV hepatitis. Eur J Gen Med. 2007;4:33.10.29333/ejgm/82424Search in Google Scholar

14. Corrales I et al. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method. Clin Vaccine Immunol. 2014;21:684.10.1128/CVI.00104-14401888724623623Search in Google Scholar

15. Crum NF. Epstein Barr virus hepatitis: case series and review. South Med J. 2006;99:544.10.1097/01.smj.0000216469.04854.2a16711324Search in Google Scholar

eISSN:
2300-6676
ISSN:
2084-980X
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy